Cargando…
Methotrexate monotherapy for unilateral moderately active thyroid‐related eye disease
A type 1 diabetic patient with unilateral active thyroid‐related eye disease was intolerant to systemic steroid therapy due to uncontrollable blood sugar levels. She was treated with low‐dose methotrexate monotherapy, which resulted in a marked improvement of her condition with no adverse events....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271214/ https://www.ncbi.nlm.nih.gov/pubmed/34267921 http://dx.doi.org/10.1002/ccr3.4559 |